| KG - King Pharmaceuticals | | Title | | King Pharmaceuticals Second Quarter 2004 Earnings | | Date and Time | | Thursday, August 5, 2004 8:00 a.m. ET | | Description | | King, headquartered in Bristol, Tennessee, is a vertically integrated pharmaceutical company that develops, manufactures, markets, and sells branded prescription pharmaceutical products. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management. |
|
|
Download the Windows Media Player or Real Player plug-in in order to listen to the webcast.
 | Unauthorized recording or downloading of this event is not permitted.
 © Copyright 2004 by Thomson Financial, Inc. All Rights Reserved. |
|